Discrepancies between fluid and crystallized ability in healthy adults: a behavioral marker of preclinical Alzheimer's disease
- 1 October 2016
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 46, 68-75
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- PET amyloid-beta imaging in preclinical Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adultsNeurology, 2012
- An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer diseaseAnnals of Neurology, 2011
- Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adultsNeurology, 2011
- Conversion of amyloid positive and negative MCI to AD over 3 yearsNeurology, 2009
- Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserveBrain, 2009
- The cortical signature of prodromal ADNeurology, 2009
- The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive IndividualsCerebral Cortex, 2008
- Cortical Surface-Based AnalysisNeuroImage, 1999
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991